Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q3 2021 call → NOWe need answer YES or NO. Need analyze transcript. Question asks: Does management describe company as currently living through a defined waiting period it is paying for out of its own pocket — present costs for something not yet earning, with specific near-dated event already visible and working toward. Need use only transcript. Let's parse. GlobalFoundries Q3 2021. They are expanding capacity. Tom: "we are really at the beginning of this journey. We expect this will become more apparent in 2022 and beyond as our revenue will continue to grow with the capacity investments we are making. And as a result of this increasing scale, we expect even faster growth in our margins and earnings." They have capacity expansion. Dresden increasing output 16% from 3Q to 4Q, Singapore Phase 1 construction on track, equipment slated second half 2022, first production first half 2023. They mention "we are capacity limited" and "we are working diligently every day to get new tooling in and get factories ramped and online so that we can produce more wafers." Gross margin improvement due to fixed cost absorption as tool out. They are investing CapEx. But is there a "defined waiting period" paying now for something not yet earning? They are paying for capacity expansion before it produces. They have customer prepayments. They are spending CapEx. But are they currently bearing real ongoing cash/earnings cost for something whose benefit hasn't arrived? They are investing in capacity, but they are also earning revenue from existing capacity. The question asks "currently living through a defined waiting period it is paying for out of its own pocket" — e.g., people hired, facility being carried before operates. Management does describe construction on Singapore Phase 1, equipment slated to go in second half 2022, first production first half 2023. That is a future expansion. They are paying for it now? They have CapEx. But is it "out of its own pocket" vs customer prepayments? They have customer prepayments and access fees. They raised IPO proceeds for capacity expansion. They are funding it. But is the cost "currently landing in results"? CapEx is not in income statement except depreciation later. They mention R&D costs, start-up costs. "R&D expense... lower due to lower fab technology start-up costs and increased customer-funded NRE." So they have fab technology start-up costs.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.